Jagsonpal Pharmaceuticals Limited — Others, 03-07-2025: Disclosure under SEBI Takeover Regulations

Jagsonpal Pharmaceuticals has announced its promoters’ annual disclosure confirming no encumbrance of shares, directly or indirectly, during the financial year. This transparency reinforces the promoters’ commitment to maintaining a clear shareholding status, which is reassuring for shareholders. No changes or risks related to pledged or charged shares have arisen, supporting stable ownership and confidence in the company’s governance.